LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 24

Search options

  1. Article ; Online: A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures.

    Vorhees, Charles V / Sprowles, Jenna N / Regan, Samantha L / Williams, Michael T

    Toxicology and applied pharmacology

    2018  Volume 354, Page(s) 176–190

    Abstract: High throughput screens for developmental neurotoxicity (DN) will facilitate evaluation of chemicals and can be used to prioritize those designated for follow-up. DN is evaluated under different guidelines. Those for drugs generally include peri- and ... ...

    Abstract High throughput screens for developmental neurotoxicity (DN) will facilitate evaluation of chemicals and can be used to prioritize those designated for follow-up. DN is evaluated under different guidelines. Those for drugs generally include peri- and postnatal studies and juvenile toxicity studies. For pesticides and commercial chemicals, when triggered, include developmental neurotoxicity studies (DNT) and extended one-generation reproductive toxicity studies. Raffaele et al. (2010) reviewed 69 pesticide DNT studies and found two of the four behavioral tests underperformed. There are now many epidemiological studies on children showing adverse neurocognitive effects, yet guideline DN studies fail to assess most of the functions affected in children; nor do DN guidelines reflect the advances in brain structure-function relationships from neuroscience. By reducing the number of test ages, removing underperforming tests and replacing them with tests that assess cognitive abilities relevant to children, the value of DN protocols can be improved. Testing for the brain networks that mediate higher cognitive functions need to include assessments of working memory, attention, long-term memory (explicit, implicit, and emotional), and executive functions such as cognitive flexibility. The current DNT focus on what can be measured should be replaced with what should be measured. With the wealth of data available from human studies and neuroscience, the recommendation is made for changes to make DN studies better focused on human-relevant functions using tests of proven validity that assess comparable functions to tests used in children. Such changes will provide regulatory authorities with more relevant data.
    MeSH term(s) Adolescent ; Age Factors ; Animals ; Behavior, Animal/drug effects ; Brain/drug effects ; Brain/growth & development ; Brain/metabolism ; Brain/pathology ; Child ; Child Behavior/drug effects ; Child Development/drug effects ; Child, Preschool ; Humans ; Infant ; Models, Animal ; Neurogenesis/drug effects ; Neurons/drug effects ; Neurons/metabolism ; Neurons/pathology ; Neuropsychological Tests ; Neurotoxicity Syndromes/etiology ; Neurotoxicity Syndromes/metabolism ; Neurotoxicity Syndromes/pathology ; Neurotoxicity Syndromes/physiopathology ; Risk Assessment ; Species Specificity ; Toxicity Tests ; Toxicology/methods
    Language English
    Publishing date 2018-03-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 204477-8
    ISSN 1096-0333 ; 0041-008X
    ISSN (online) 1096-0333
    ISSN 0041-008X
    DOI 10.1016/j.taap.2018.03.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Skeletal muscle Ca(2+) mishandling: Another effect of bone-to-muscle signaling.

    Regan, Jenna N / Waning, David L / Guise, Theresa A

    Seminars in cell & developmental biology

    2016  Volume 49, Page(s) 24–29

    Abstract: Our appreciation of crosstalk between muscle and bone has recently expanded beyond mechanical force-driven events to encompass a variety of signaling factors originating in one tissue and communicating to the other. While the recent identification of new ...

    Abstract Our appreciation of crosstalk between muscle and bone has recently expanded beyond mechanical force-driven events to encompass a variety of signaling factors originating in one tissue and communicating to the other. While the recent identification of new 'myokines' has shifted some focus to the role of muscle in this partnership, bone-derived factors and their effects on skeletal muscle should not be overlooked. This review summarizes some previously known mediators of bone-to-muscle signaling and also recent work identifying a new role for bone-derived TGF-β as a cause of skeletal muscle weakness in the setting of cancer-induced bone destruction. Oxidation of the ryanodine receptor/calcium release channel (RyR1) in skeletal muscle occurs via a TGF-β-Nox4-RyR1 axis and leads to calcium mishandling and decreased muscle function. Multiple points of potential therapeutic intervention were identified, from preventing the bone destruction to stabilizing the RYR1 calcium channel. This new data reinforces the concept that bone can be an important source of signaling factors in pathphysiological settings.
    MeSH term(s) Animals ; Bone Neoplasms/metabolism ; Bone Neoplasms/pathology ; Bone and Bones/metabolism ; Calcium/metabolism ; Calcium Signaling ; Cell Communication ; Humans ; Muscle Weakness/metabolism ; Muscle Weakness/pathology ; Muscle, Skeletal/metabolism ; Oxidative Stress ; Transforming Growth Factor beta/physiology
    Chemical Substances Transforming Growth Factor beta ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2016-01
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1312473-0
    ISSN 1096-3634 ; 1084-9521
    ISSN (online) 1096-3634
    ISSN 1084-9521
    DOI 10.1016/j.semcdb.2015.11.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Role of TGFβ in Bone-Muscle Crosstalk.

    Regan, Jenna N / Trivedi, Trupti / Guise, Theresa A / Waning, David L

    Current osteoporosis reports

    2017  Volume 15, Issue 1, Page(s) 18–23

    Abstract: Purpose of review: The role of bone-derived factors in regulation of skeletal muscle function is an important emerging aspect of research into bone-muscle crosstalk. Implications for this area of research are far reaching and include understanding ... ...

    Abstract Purpose of review: The role of bone-derived factors in regulation of skeletal muscle function is an important emerging aspect of research into bone-muscle crosstalk. Implications for this area of research are far reaching and include understanding skeletal muscle weakness in cancer, osteoporosis, cachexia, rare diseases of bone, and aging.
    Recent findings: Recent research shows that bone-derived factors can lead to changes in the skeletal muscle. These changes can either be anabolic or catabolic, and we focus this review on the role of TGFβ in driving oxidative stress and skeletal muscle weakness in the setting of osteolytic cancer in the bone. The bone is a preferred site for breast cancer metastasis and leads to pathological bone loss. Osteolytic cancer in the bone leads to release of TGFβ from the bone via osteoclast-mediated bone destruction. Our appreciation of crosstalk between the muscle and bone has recently expanded beyond mechanical force-driven events to encompass a variety of signaling factors originating in one tissue and communicating to the other. This review summarizes some previously known mediators of bone-to-muscle signaling and also recent work identifying a new role for bone-derived TGFβ as a cause of skeletal muscle weakness in the setting of osteolytic cancer in the bone. Multiple points of potential therapeutic intervention are discussed.
    MeSH term(s) Bone Neoplasms/metabolism ; Bone Neoplasms/secondary ; Bone and Bones/metabolism ; Humans ; Muscle Weakness/metabolism ; Muscle, Skeletal/metabolism ; Oxidative Stress ; Signal Transduction ; Transforming Growth Factor beta/metabolism
    Chemical Substances Transforming Growth Factor beta
    Language English
    Publishing date 2017-02-03
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2186581-4
    ISSN 1544-2241 ; 1544-1873
    ISSN (online) 1544-2241
    ISSN 1544-1873
    DOI 10.1007/s11914-017-0344-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Building a vessel wall with notch signaling.

    Regan, Jenna N / Majesky, Mark W

    Circulation research

    2009  Volume 104, Issue 4, Page(s) 419–421

    MeSH term(s) Animals ; Blood Vessels/cytology ; Blood Vessels/metabolism ; Calcium-Binding Proteins/metabolism ; Cattle ; Endothelial Cells/metabolism ; Fibroblasts/metabolism ; Humans ; Intercellular Signaling Peptides and Proteins/metabolism ; Membrane Proteins/metabolism ; Muscle, Smooth, Vascular/metabolism ; Myocytes, Smooth Muscle/metabolism ; Neovascularization, Physiologic ; Paracrine Communication ; Pericytes/metabolism ; Receptor, Notch3 ; Receptors, Notch/metabolism ; Serrate-Jagged Proteins ; Signal Transduction
    Chemical Substances Calcium-Binding Proteins ; Intercellular Signaling Peptides and Proteins ; Membrane Proteins ; NOTCH3 protein, human ; Receptor, Notch3 ; Receptors, Notch ; Serrate-Jagged Proteins
    Language English
    Publishing date 2009-02-26
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.109.194233
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model.

    Regan, Jenna N / Mikesell, Carter / Reiken, Steven / Xu, Haifang / Marks, Andrew R / Mohammad, Khalid S / Guise, Theresa A / Waning, David L

    Frontiers in endocrinology

    2017  Volume 8, Page(s) 358

    Abstract: Muscle weakness and cachexia are significant paraneoplastic syndromes of many advanced cancers. Osteolytic bone metastases are common in advanced breast cancer and are a major contributor to decreased survival, performance, and quality of life for ... ...

    Abstract Muscle weakness and cachexia are significant paraneoplastic syndromes of many advanced cancers. Osteolytic bone metastases are common in advanced breast cancer and are a major contributor to decreased survival, performance, and quality of life for patients. Pathologic fracture caused by osteolytic cancer in bone (OCIB) leads to a significant (32%) increased risk of death compared to patients without fracture. Since muscle weakness is linked to risk of falls which are a major cause of fracture, we have investigated skeletal muscle response to OCIB. Here, we show that a syngeneic mouse model of OCIB (4T1 mammary tumor cells) leads to cachexia and skeletal muscle weakness associated with oxidation of the ryanodine receptor and calcium (Ca
    Language English
    Publishing date 2017
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2017.00358
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Therapeutic targeting of immune checkpoints with small molecule inhibitors.

    Smith, Wade M / Purvis, Ian J / Bomstad, Colin N / Labak, Collin M / Velpula, Kiran K / Tsung, Andrew J / Regan, Jenna N / Venkataraman, Sujatha / Vibhakar, Rajeev / Asuthkar, Swapna

    American journal of translational research

    2019  Volume 11, Issue 2, Page(s) 529–541

    Abstract: Immune checkpoints are known to contribute to tumor progression by enhancing cancer's ability to evade the immune system and metastasize. Immunotherapies, including monoclonal antibodies, have been developed to target specific immunosuppressive molecules ...

    Abstract Immune checkpoints are known to contribute to tumor progression by enhancing cancer's ability to evade the immune system and metastasize. Immunotherapies, including monoclonal antibodies, have been developed to target specific immunosuppressive molecules on the membranes of cancer cells and have proven revolutionary in the field of oncology. Recently, small molecule inhibitors (SMIs) have gained increased attention in cancer research with potential applications in immunotherapy. SMIs have desirable benefits over large-molecule inhibitors, such as monoclonal antibodies, including greater cell permeability, organ specificity, longer half-lives, cheaper production costs, and the possibility for oral administration. This paper will review the mechanisms by which noteworthy and novel immune checkpoints contribute to tumor progression, and how they may be targeted by SMIs and epigenetic modifiers to offer possible adjuvants to established therapeutic regimens. SMIs target immune checkpoints in several ways, such as blocking signaling between tumorigenic factors, building immune tolerance, and direct inhibition via epigenetic repression of immune inhibitory molecules. Further investigation into combination therapies utilizing SMIs and conventional cancer therapies will uncover new treatment options that may provide better patient outcomes across a range of cancers.
    Language English
    Publishing date 2019-02-15
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2471058-1
    ISSN 1943-8141
    ISSN 1943-8141
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The P2Y

    Qian, Shaomin / Regan, Jenna N / Shelton, Maxwell T / Hoggatt, April / Mohammad, Khalid S / Herring, Paul B / Seye, Cheikh I

    Atherosclerosis

    2017  Volume 257, Page(s) 38–46

    Abstract: Background and aims: Mutations in the 5'-nucleotidase ecto (NT5E) gene that encodes CD73, a nucleotidase that converts AMP to adenosine, are linked to arterial calcification. However, the role of purinergic receptor signaling in the pathology of intimal ...

    Abstract Background and aims: Mutations in the 5'-nucleotidase ecto (NT5E) gene that encodes CD73, a nucleotidase that converts AMP to adenosine, are linked to arterial calcification. However, the role of purinergic receptor signaling in the pathology of intimal calcification is not well understood. In this study, we examined whether extracellular nucleotides acting via P2Y
    Methods: Apolipoprotein E, P2Y
    Results: P2Y
    Conclusions: This study reveals a role for vascular P2Y
    MeSH term(s) 5'-Nucleotidase/metabolism ; Animals ; Aorta/metabolism ; Aorta/pathology ; Aortic Diseases/genetics ; Aortic Diseases/metabolism ; Aortic Diseases/pathology ; Aortic Diseases/prevention & control ; Apolipoproteins E/deficiency ; Apolipoproteins E/genetics ; Atherosclerosis/genetics ; Atherosclerosis/metabolism ; Atherosclerosis/pathology ; Atherosclerosis/prevention & control ; Cell Transdifferentiation ; Cells, Cultured ; Core Binding Factor Alpha 1 Subunit/genetics ; Core Binding Factor Alpha 1 Subunit/metabolism ; Disease Models, Animal ; GPI-Linked Proteins/metabolism ; Genetic Predisposition to Disease ; Male ; Mice, Inbred C57BL ; Mice, Knockout ; Muscle, Smooth, Vascular/metabolism ; Muscle, Smooth, Vascular/pathology ; Myocytes, Smooth Muscle/metabolism ; Myocytes, Smooth Muscle/pathology ; Osteoblasts/metabolism ; Osteoblasts/pathology ; Osteocalcin/genetics ; Osteocalcin/metabolism ; Phenotype ; Promoter Regions, Genetic ; Receptors, Purinergic P2Y2/deficiency ; Receptors, Purinergic P2Y2/genetics ; Receptors, Purinergic P2Y2/metabolism ; Transfection ; Vascular Calcification/genetics ; Vascular Calcification/metabolism ; Vascular Calcification/pathology ; Vascular Calcification/prevention & control
    Chemical Substances Apolipoproteins E ; Core Binding Factor Alpha 1 Subunit ; GPI-Linked Proteins ; P2ry2 protein, mouse ; Receptors, Purinergic P2Y2 ; Runx2 protein, mouse ; Osteocalcin (104982-03-8) ; 5'-Nucleotidase (EC 3.1.3.5) ; Nt5e protein, mouse (EC 3.1.3.5)
    Language English
    Publishing date 2017-02
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 80061-2
    ISSN 1879-1484 ; 0021-9150
    ISSN (online) 1879-1484
    ISSN 0021-9150
    DOI 10.1016/j.atherosclerosis.2016.12.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Vascular smooth muscle progenitor cells: building and repairing blood vessels.

    Majesky, Mark W / Dong, Xiu Rong / Regan, Jenna N / Hoglund, Virginia J

    Circulation research

    2011  Volume 108, Issue 3, Page(s) 365–377

    Abstract: Molecular pathways that control the specification, migration, and number of available smooth muscle progenitor cells play key roles in determining blood vessel size and structure, capacity for tissue repair, and progression of age-related disorders. ... ...

    Abstract Molecular pathways that control the specification, migration, and number of available smooth muscle progenitor cells play key roles in determining blood vessel size and structure, capacity for tissue repair, and progression of age-related disorders. Defects in these pathways produce malformations of developing blood vessels, depletion of smooth muscle progenitor cell pools for vessel wall maintenance and repair, and aberrant activation of alternative differentiation pathways in vascular disease. A better understanding of the molecular mechanisms that uniquely specify and maintain vascular smooth muscle cell precursors is essential if we are to use advances in stem and progenitor cell biology and somatic cell reprogramming for applications directed to the vessel wall.
    MeSH term(s) Animals ; Blood Vessels/cytology ; Blood Vessels/physiology ; Cell Differentiation/physiology ; Epigenomics ; Humans ; Mesenchymal Stem Cells/cytology ; Mesenchymal Stem Cells/physiology ; Muscle, Smooth, Vascular/cytology ; Muscle, Smooth, Vascular/physiology ; Regeneration/physiology
    Language English
    Publishing date 2011-02-03
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.110.223800
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Tbx18 regulates development of the epicardium and coronary vessels.

    Wu, San-Pin / Dong, Xiu-Rong / Regan, Jenna N / Su, Chang / Majesky, Mark W

    Developmental biology

    2013  Volume 383, Issue 2, Page(s) 307–320

    Abstract: The epicardium and coronary vessels originate from progenitor cells in the proepicardium. Here we show that Tbx18, a T-box family member highly expressed in the proepicardium, controls critical early steps in coronary development. In Tbx18(-/-) mouse ... ...

    Abstract The epicardium and coronary vessels originate from progenitor cells in the proepicardium. Here we show that Tbx18, a T-box family member highly expressed in the proepicardium, controls critical early steps in coronary development. In Tbx18(-/-) mouse embryos, both the epicardium and coronary vessels exhibit structural and functional defects. At E12.5, the Tbx18-deficient epicardium contains protrusions and cyst-like structures overlying a disorganized coronary vascular plexus that contains ectopic structures resembling blood islands. At E13.5, the left and right coronary stems form correctly in mutant hearts. However, analysis of PECAM-1 whole mount immunostaining, distribution of SM22α(lacZ/+) activity, and analysis of coronary vascular casts suggest that defective vascular plexus remodeling produces a compromised arterial network at birth consisting of fewer distributing conduit arteries with smaller lumens and a reduced capacity to conduct blood flow. Gene expression profiles of Tbx18(-/-) hearts at E12.5 reveal altered expression of 79 genes that are associated with development of the vascular system including sonic hedgehog signaling components patched and smoothened, VEGF-A, angiopoietin-1, endoglin, and Wnt factors compared to wild type hearts. Thus, formation of coronary vasculature is responsive to Tbx18-dependent gene targets in the epicardium, and a poorly structured network of coronary conduit vessels is formed in Tbx18 null hearts due to defects in epicardial cell signaling and fate during heart development. Lastly, we demonstrate that Tbx18 possesses a SRF/CArG box dependent repressor activity capable of inhibiting progenitor cell differentiation into smooth muscle cells, suggesting a potential function of Tbx18 in maintaining the progenitor status of epicardial-derived cells.
    MeSH term(s) Animals ; Animals, Newborn ; Cell Differentiation ; Coronary Circulation ; Coronary Vessels/embryology ; Coronary Vessels/metabolism ; Coronary Vessels/pathology ; Coronary Vessels/ultrastructure ; Embryo, Mammalian/metabolism ; Embryo, Mammalian/pathology ; Gene Expression Profiling ; Gene Expression Regulation, Developmental ; Mice ; Myocytes, Smooth Muscle/metabolism ; Pericardium/embryology ; Pericardium/metabolism ; Pericardium/pathology ; Pericardium/ultrastructure ; Repressor Proteins/metabolism ; Serum Response Factor/chemistry ; T-Box Domain Proteins/deficiency ; T-Box Domain Proteins/genetics ; T-Box Domain Proteins/metabolism ; Transcription, Genetic ; beta-Galactosidase/metabolism
    Chemical Substances Repressor Proteins ; Serum Response Factor ; T-Box Domain Proteins ; Tbx18 protein, mouse ; beta-Galactosidase (EC 3.2.1.23)
    Language English
    Publishing date 2013-09-07
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1114-9
    ISSN 1095-564X ; 0012-1606
    ISSN (online) 1095-564X
    ISSN 0012-1606
    DOI 10.1016/j.ydbio.2013.08.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Up-regulation of glycolytic metabolism is required for HIF1α-driven bone formation.

    Regan, Jenna N / Lim, Joohyun / Shi, Yu / Joeng, Kyu Sang / Arbeit, Jeffrey M / Shohet, Ralph V / Long, Fanxin

    Proceedings of the National Academy of Sciences of the United States of America

    2014  Volume 111, Issue 23, Page(s) 8673–8678

    Abstract: The bone marrow environment is among the most hypoxic in the body, but how hypoxia affects bone formation is not known. Because low oxygen tension stabilizes hypoxia-inducible factor alpha (HIFα) proteins, we have investigated the effect of expressing a ... ...

    Abstract The bone marrow environment is among the most hypoxic in the body, but how hypoxia affects bone formation is not known. Because low oxygen tension stabilizes hypoxia-inducible factor alpha (HIFα) proteins, we have investigated the effect of expressing a stabilized form of HIF1α in osteoblast precursors. Brief stabilization of HIF1α in SP7-positive cells in postnatal mice dramatically stimulated cancellous bone formation via marked expansion of the osteoblast population. Remarkably, concomitant deletion of vascular endothelial growth factor A (VEGFA) in the mouse did not diminish bone accrual caused by HIF1α stabilization. Thus, HIF1α-driven bone formation is independent of VEGFA up-regulation and increased angiogenesis. On the other hand, HIF1α stabilization stimulated glycolysis in bone through up-regulation of key glycolytic enzymes including pyruvate dehydrogenase kinase 1 (PDK1). Pharmacological inhibition of PDK1 completely reversed HIF1α-driven bone formation in vivo. Thus, HIF1α stimulates osteoblast formation through direct activation of glycolysis, and alterations in cellular metabolism may be a broadly applicable mechanism for regulating cell differentiation.
    MeSH term(s) Animals ; Blotting, Western ; Bone Marrow/metabolism ; Bone Marrow Cells/metabolism ; Bone and Bones/cytology ; Bone and Bones/metabolism ; Cell Hypoxia ; Female ; Glycolysis/genetics ; Glycolysis/physiology ; Green Fluorescent Proteins/genetics ; Green Fluorescent Proteins/metabolism ; Hypoxia ; Hypoxia-Inducible Factor 1, alpha Subunit/genetics ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Immunohistochemistry ; Male ; Mice ; Mice, Knockout ; Mice, Transgenic ; Microscopy, Confocal ; Osteoblasts/cytology ; Osteoblasts/metabolism ; Osteogenesis/genetics ; Osteogenesis/physiology ; Protein-Serine-Threonine Kinases/antagonists & inhibitors ; Protein-Serine-Threonine Kinases/metabolism ; Pyruvate Dehydrogenase Acetyl-Transferring Kinase ; Sp7 Transcription Factor ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Up-Regulation ; Vascular Endothelial Growth Factor A/genetics ; Vascular Endothelial Growth Factor A/metabolism
    Chemical Substances Hif1a protein, mouse ; Hypoxia-Inducible Factor 1, alpha Subunit ; Pdk1 protein, mouse ; Pyruvate Dehydrogenase Acetyl-Transferring Kinase ; Sp7 Transcription Factor ; Sp7 protein, mouse ; Transcription Factors ; Vascular Endothelial Growth Factor A ; vascular endothelial growth factor A, mouse ; Green Fluorescent Proteins (147336-22-9) ; Protein-Serine-Threonine Kinases (EC 2.7.11.1)
    Language English
    Publishing date 2014-05-27
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1324290111
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top